Home › Funds › Murphy, Middleton, Hinkle & Parker, Inc. › JNJ

Murphy, Middleton, Hinkle & Parker, Inc. position in JNJ

JOHNSON JOHNSON · Health Care

Murphy, Middleton, Hinkle & Parker, Inc. reported holding 25,547 shares of JNJ (JOHNSON JOHNSON) in its Q3 2026 13F filing — a position valued at US$6.8M, representing 2.75% of its reported portfolio and ranking #9 among its reported holdings. Murphy, Middleton, Hinkle & Parker, Inc. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)25.55K sh
Reported value held$6.76M
Portfolio Weight2.75%
First reportedQ3 2023
Last changeReduce
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How Murphy, Middleton, Hinkle & Parker, Inc.'s JNJ position evolved

Murphy, Middleton, Hinkle & Parker, Inc. first disclosed a stake in JNJ in Q3 2023 at 27,764 shares (US$4.3M). The position peaked in Q3 2026 at 25,547 shares, worth US$6.8M. Across 13 filings, Murphy, Middleton, Hinkle & Parker, Inc. increased the stake 1 time(s), trimmed it 5 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 25,547 shares valued at US$6.8M — a reduction of -371 shares quarter over quarter.. Notable position changes include a 91% trim in Q4 2025 (shares rose 18% over the following quarter), a 1053% increase in Q1 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 27.76K $4.32M New
Q4 2023 27.64K $4.33M Hold
Q1 2024 27.32K $4.32M Reduce
Q2 2024 27.32K $3.99M Hold
Q3 2024 27.01K $4.38M Reduce
Q4 2024 25.98K $3.76M Reduce
Q1 2025 25.96K $4.30M Hold
Q2 2025 25.96K $4.30M Hold
Q3 2025 25.85K $4.79M Hold
Q4 2025 2.25K $252.21K Reduce
Q1 2026 25.91K $6.33M Add
Q2 2026 25.92K $6.58M Hold
Q3 2026 25.55K $6.76M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Murphy, Middleton, Hinkle & Parker, Inc. held JNJ?

Murphy, Middleton, Hinkle & Parker, Inc. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Murphy, Middleton, Hinkle & Parker, Inc.'s current position in JNJ?

As of Q3 2026, Murphy, Middleton, Hinkle & Parker, Inc. holds 25.55K shares of JNJ (JOHNSON JOHNSON), valued at $6.76M, representing 2.75% of its reported portfolio and ranking #9.

Has Murphy, Middleton, Hinkle & Parker, Inc. been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Murphy, Middleton, Hinkle & Parker, Inc. reduced its position in JNJ. The position peaked in Q3 2026 at 25.55K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.